Pathophysiology of Prurigo Nodularis: Neuroimmune Dysregulation and the Role of Type 2 Inflammation

被引：0
|
作者：
Kwatra, Shawn G. [1 ,2 ]
Staender, Sonja [3 ,4 ]
Yosipovitch, Gil [5 ]
Kim, Brian S. [6 ]
Levit, Noah A. [7 ]
O'Malley, John T. [8 ]
机构：
[1] Univ Maryland, Sch Med, Dept Dermatol, Baltimore, MD USA
[2] Univ Maryland, Sch Med, Maryland Itch Ctr, Baltimore, MD USA
[3] Univ Hosp Munster, Dept Dermatol, Munster, Germany
[4] Univ Hosp Munster, Ctr Chron Pruritus, Munster, Germany
[5] Univ Miami, Miami Itch Ctr, Dr Philip Frost Dept Dermatol & Cutaneous Surg, Miami, FL USA
[6] Icahn Sch Med Mt Sinai, Mark Lebwohl Ctr Neuroinflammat & Sensat, Dept Dermatol, New York, NY USA
[7] Dermatol Phys Connecticut, Fairfield, CT USA
[8] Sanofi, 450 Water St, Cambridge, MA 02141 USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2025年 / 145卷 / 02期
关键词：
Neuroimmune axis; Pathophysiology; Prurigo nodularis; Type; 2; immunity; NERVE GROWTH-FACTOR; IMMUNOREACTIVE NERVES; TRIAL; PATHOGENESIS; NEMOLIZUMAB; EXPLORATION; BURDEN; ITCH; SKIN;
D O I：
10.1016/j.jid.2024.06.1276
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
Prurigo nodularis (PN) is a chronic, inflammatory skin condition characterized by multiple, intensely pruritic, distinctive nodular lesions. Subsequent scratching can further intensify the pruritus, culminating in a self-reinforcing itch-scratch cycle, which drives lesion development. The latest data indicate dysregulation of the neuroimmune axis in PN pathogenesis, including the involvement of sensory neurons, key effector immune cells, proinflammatory cytokines, dermal fibroblasts, and pruritogens. In this review, we highlight evidence supporting the role of type 2 immune axis dysregulation in driving the clinical presentation of PN and discuss how related signaling pathways may offer effective therapeutic targets to control PN signs and symptoms.
引用
收藏
页码：249 / 256
页数：8
相关论文
共 50 条
  • [1] Modulation of Neuroimmune and Epithelial Dysregulation in Patients With Moderate to Severe Prurigo Nodularis Treated With Nemolizumab
    Deng, Junwen
    Liao, Viviane
    Parthasarathy, Varsha
    Cornman, Hannah L.
    Kambala, Anusha
    Kwatra, Madan M.
    Stander, Sonja
    Piketty, Christophe
    Chaskar, Prasad
    Krishnaswamy, Jayendra Kumar
    Julia, Valerie
    Kwatra, Shawn G.
    JAMA DERMATOLOGY, 2023, 159 (09) : 977 - 985
  • [2] Prurigo nodularis forecast: Light type 2 inflammation with high chances of fibrosis
    Conrad, Curdin
    Schlapbach, Christoph
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (01) : 93 - 94
  • [3] Pathophysiology, diagnosis, and pharmacological treatment of prurigo nodularis
    Williams, Kyle A.
    Roh, Youkyung S.
    Brown, Isabelle
    Sutaria, Nishadh
    Bakhshi, Pegah
    Choi, Justin
    Gabriel, Sylvie
    Chavda, Rajeev
    Kwatra, Shawn G.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2021, 14 (01) : 67 - 77
  • [4] Comprehensive plasma cytokine and chemokine profiling in prurigo nodularis reveals endotypes in Type 2 inflammation
    Cornman, Hannah L.
    Manjunath, Jaya
    Reddy, Sriya V.
    Adams, Jackson
    Rajeh, Ahmad
    Samuel, Christeen
    Bao, Aaron
    Zhao, Ryan
    Ma, Emily Z.
    Shumsky, Jason
    Pritchard, Thomas W.
    Imo, Brenda Umenita
    Kollhoff, Alexander L.
    Lee, Kevin K.
    Lu, Weiying
    Yossef, Selina
    Kwatra, Madan M.
    Kwatra, Shawn G.
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [5] Epidermal differentiation, inflammation, and serum levels of filaggrin and IgE in atopic dermatitis, classical prurigo nodularis and prurigo nodularis in AD
    Proksch, E.
    Hohmuth, A.
    Reimer, R.
    Foelster-Holst, R.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (10) : S219 - S219
  • [6] Type-IV-Sensitization in Patients with Prurigo nodularis
    Weisshaar, E.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2017, 15 : 17 - 17
  • [7] Prurigo nodularis: A rare presentation of neurofibromatosis type 1
    Thompson, Agnieszka
    Babovic-Vuksanovic, Dusica
    Hand, Jennifer
    Drage, Lisa
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB108 - AB108
  • [8] Role of dupilumab in pediatric prurigo nodularis: Beyond the skin
    Oliveira, Joao
    Nogueira, Miguel
    Pinto, Diana
    Machado, Susana
    Araujo, Ana Rita
    Teixeira, Fernanda
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2023, 34 (01)
  • [9] Can Serum Biomarkers for Prurigo Nodularis Expose Pathophysiology or Just Treatment Response?
    Kashem, Sakeen W. W.
    Fassett, Marlys S. S.
    JAMA DERMATOLOGY, 2023, 159 (09) : 915 - 917
  • [10] CGRP-immunoreactive nerves in prurigo nodularis - an exploration of neurogenic inflammation
    Liang, Y
    Jacobi, HH
    Reimert, CM
    Haak-Frendscho, M
    Marcusson, JA
    Johansson, O
    JOURNAL OF CUTANEOUS PATHOLOGY, 2000, 27 (07) : 359 - 366
12345